Elsevier

Journal of Clinical Virology

Volume 62, January 2015, Pages 54-57
Journal of Clinical Virology

Case report
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome

https://doi.org/10.1016/j.jcv.2014.11.021Get rights and content

Highlights

  • Parvovirus B19 infection can be involved in the pathogenesis of CFS.

  • Previous reports described a favourable outcome of CFS following IVIG treatment.

  • In our case IVIG treatment led to a paradoxical clinical and virological response.

  • IVIG administration in the treatment of B19V-associated CFS should be reconsidered.

Abstract

We describe a case of chronic fatigue syndrome (CFS) associated to Parvovirus B19 infection where administration of intravenous immunoglobulins (IVIG), previously reported as effective, induced a paradoxical clinical response and increased viral replication. The indication of IVIG administration in the treatment of Parvovirus B19-associated CFS should be carefully reconsidered.

Section snippets

Why this case is important?

The chronic fatigue syndrome (CFS) remains a challenging clinical entity with several expressions overlapping with infectious and autoimmune disorders. According to several pathogenetic hypotheses, in patients with susceptible genetic background, a persisting antigenic/infectious stimulation may trigger a chronic immune activation and upregulation of pro-inflammatory cytokines leading to CFS [1]. Evidence shows that chronic Parvovirus B19 (B19V) infection can be involved in the pathogenesis of

Case description

A 42-year old Italian man was referred (May 2012) to the Infectious Diseases Unit at the S.Orsola-Malpighi University Hospital (Bologna, Italy) with a previous diagnosis of CFS associated with B19V infection. His past medical history included a pericarditis of possible viral origin (18 years before), Gilbert syndrome, and allergic rhinitis-conjunctivitis.

At disease onset, five years earlier, the patient exhibited high-titre anti-B19V serum IgM that progressively declined over 18 months,

Other similar and contrasting cases in the literature

CFS is a composite disorder with variable presentation and clinical course, where ethiopathogenetic pathways may depend on the patient-specific genetic background, different underlying immune response, and a broad spectrum of possible triggering agents. A relevant portion of CFS cases do recognize a directly- or indirectly-mediated infectious disease origin [1]. In these cases, the appropriate treatment of an active infection may significantly contribute to the outcome of CFS. To the best of

Discussion

In our case, repeated high-dose IVIG treatment failed in producing a successful clinical outcome. On the contrary, our patient complained of a transient re-appearance of the most severe signs-symptoms already experienced at disease onset, and symptom exacerbations were accompanied by increased viraemia. Evaluation of immunological responses upon IVIG administration showed no major changes, except for increased levels of B-cell activation. Further, in vitro investigation demonstrated that the

Funding

This work was supported by the University of Bologna (RFO 2010–2012).

Competing interest

None declared.

Ethical approval

Not applicable.

Acknowledgments

We gratefully acknowledge Dr. Daniela Barbieri, PhD, from the Department of Diagnostic, Experimental and Specialty Medicine of the University of Bologna, for valuable suggestions and discussion of data.

References (14)

There are more references available in the full text version of this article.

Cited by (0)

View full text